Human Immunity Against Staphylococcus Aureus Skin Infection

NCT02262819 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

NIH

Sponsor class

Conditions

Staphylococcus Aureus Skin Infection

Interventions

DRUG: S. aureus

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)